David Cutler the candidate for President-Elect and Robin McKnight the candidate for Secretary are both running uncontested. There are three directors positions available. Vote for three out of the six candidates. The three candidates with the highest vote totals will be elected to the ASHEcon Board of Directors.
Board of Directors – 3 positions
Vote by Monday, April 13, 2020 at 11:59 p.m. ET.
How to Vote
Voting is limited to current ASHEcon Members – one member, one vote. Once the Voter ID is used, it cannot be used again. Your assigned Secure Voter ID, will be sent to you via e-mail, will be utilized to validate your ballot.
If you don’t receive a ballot and you are a current member, do not hesitate to email Leslie Ofori at firstname.lastname@example.org
Uncontested; serves a 1-year term, automatically becomes ASHEcon President after the 2020 Annual Conference.
David Cutler is currently the Otto Eckstein Professor of Applied Economics in the Department of Economics and was named Harvard College Professor in 2014 until 2019. He has developed an impressive record of achievement in both academia and the public sector. He served as Assistant Professor of Economics from 1991 to 1995, was named John L. Loeb Associate Professor of Social Sciences in 1995 and received tenure in 1997. Professor Cutler holds secondary appointments at the Kennedy School of Government and the School of Public Health. Professor Cutler was associate dean of the Faculty of Arts and Sciences for Social Sciences from 2003-2008. Honored for his scholarly work and singled out for outstanding mentorship of graduate students, Professor Cutler’s work in health economics and public economics has earned him significant academic and public acclaim. Professor Cutler served on the Council of Economic Advisers and the National Economic Council during the Clinton Administration and has advised the Presidential campaigns of Bill Bradley, John Kerry, and Barack Obama as well as being Senior Health Care Advisor for the Obama Presidential Campaign. Currently, Professor Cutler is a Research Associate at the National Bureau of Economic Research, a member of the Institute of Medicine, and a Fellow of the Employee Benefit Research Institute. He advises many companies and groups on health care.
You can view his CV here: https://scholar.harvard.edu/files/cutler/files/2019_07_01_cutler_cv.pdf
Uncontested; serves a 4-year term
Robin McKnight is a Professor of Economics at Wellesley College, where she has been a faculty member since 2008. She is also a Research Associate at the National Bureau of Economic Research in the Aging and Health Care programs. She has served on the Board of Directors of ASHEcon for the past four years, and is an Associate Editor at the Journal of Health Economics.
Robin earned a Ph.D. in economics from the Massachusetts Institute of Technology in 2002, and a B.A. in economics from Amherst College in 1995. Prior to joining the Wellesley faculty, she was on the faculty at the University of Oregon.
Robin’s research has focused on the economics of health insurance, especially issues arising from government intervention in health insurance markets. Past research projects have examined, among other things, the impacts of incentives faced by providers through reimbursement policy and by patients through copayment policies. Her recent research has analyzed patterns of mortality from firearms.
You can view her CV here: https://www.wellesley.edu/sites/default/files/mcknight_cv1_0.pdf
Board of Directors
Three people will be elected for a 4-year term.
Dr. Ellen Meara is a professor of health economics and policy in the Department of Health Policy and Management at Harvard’s TH Chan School of Public Health. Her research spans a wide range of subjects in the economics of health and medical care, with emphasis in three areas: determinants and consequences of participation in health and disability insurance; the role of payment and delivery reforms on health care use and outcomes; and trends in mortality and health care spending over time. Much of her recent work has been focused on mental health and substance abuse, particularly the opioid crisis. Dr. Meara has studied how state policies affect opioid use, and consequences of opioid use among adults who are Medicare-eligible due to a disability. She is currently studying how features of health care systems and recent payment and delivery reforms influence care for patients with complex clinical and social needs.
Dr. Meara received a BA in mathematical models for social sciences and political science from Northwestern University and a PhD in economics from Harvard University. In 1999, Dr. Meara joined the Department of Health Care Policy at Harvard Medical School as an assistant professor. She was promoted to associate professor in 2008 and held that position until 2010. While at Harvard Medical School, she was affiliated with the Center on the Developing Child, where she was also a steering committee member. In 2010, Dr. Meara joined the Dartmouth Institute for Health Policy & Clinical Practice of the Geisel School of Medicine at Dartmouth College as an associate professor. She was promoted to professor in 2016, and became co-faculty director of the Master of Health Care Delivery Science program the same year. She is a research associate of the National Bureau of Economic Research. Dr. Meara served as co-editor of the Journal of Health Economics from 2014 to 2018. In 2018, she was appointed Peggy Y. Thomson Professor in the Evaluative Clinical Sciences, and in 2019, Dr. Meara was elected to the National Academy of Medicine.
Amitabh Chandra is the Ethel Zimmerman Wiener Professor of Public Policy and Director of Health Policy Research at Harvard University’s John F. Kennedy School of Government. He teaches undergraduates in Harvard College, graduate students at the Kennedy School Business School, and in Harvard’s Executive Education programs. Professor Chandra is a member of the Congressional Budget Office’s (CBO) Panel of Health Advisors, and is a Research Associate at the National Bureau of Economic Research (NBER). His research focuses on innovation and cost-growth in healthcare, medical malpractice, and racial disparities in healthcare. His research has been supported by the National Institute of Aging, the National Institute of Child Health and Development, the Robert Wood Johnson Foundation, and has been published in the American Economic Review, the Journal of Political Economy, the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the Chair Editor of the Review of Economics and Statistics.
Chandra has testified to the United States Senate and the United States Commission on Civil Rights. His research has been featured in the New York Times, the Washington Post, CNN, Newsweek, and on National Public Radio. He has been a consultant to the RAND Corporation, Microsoft Research, the Institute of Medicine and the Blue Cross Blue Shield Foundation of Massachusetts. In 2011 he served as Massachusetts’ Special Commissioner on Provider Price Reform.
You can view his CV here: https://apps.hks.harvard.edu/faculty/cv/AmitabhChandra.pdf
Darrell J. Gaskin, PhD MS is the William C. and Nancy F. Richardson Professor in Health Policy and Director of the Hopkins Center for Health Disparities Solutions at the Johns Hopkins Bloomberg School of Public Health in the Department of Health Policy and Management. Dr. Gaskin is a health economist and a health services researcher. He is an internationally recognized expert in health and healthcare disparities. He seeks to identify and understand place-based barriers to care for low income, minorities and other vulnerable populations; to develop and promote policies and practices that address the social determinants of health to improve access to care, quality of care and health care outcomes; and to promote equity in well-being, health and health care by race, ethnicity, socioeconomic status and geography. He serves on the Board of Scientific Counselors of the National Center for Health Statistics of the Centers for Disease Control and Prevention. He chairs the National Advisory Committee of the Robert Wood Johnson Foundation’s System for Action program. Also, he serves on the Board of Directors of AcademyHealth. He is a 2019 recipient of the Presidential Early Career Award for Scientists and Engineers. His Ph.D. is in public health economics from the Johns Hopkins University. He holds a MS degree in economics from the Massachusetts Institute of Technology, and a BA degree in economics from Brandeis University.
You can view his CV here: https://www.jhsph.edu/faculty/directory/profile/51/darrell-j-gaskin
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. With offices in Durham, NC and Washington, DC, the Duke-Margolis Center is a university-wide, interdisciplinary initiative that is nationally and internationally recognized for its research, evaluation, implementation, and educational initiatives to improve health and health policy. The Center integrates Duke’s expertise in the social, clinical, and analytical sciences with health care leader and stakeholder engagement to develop and apply policy solutions that improve health and the value of health care locally, nationally, and worldwide. ark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University. Dr. McClellan is a physician and an economist who has informed and improved a wide range of strategies and policy reforms to advance health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These reforms include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He previously served as a member of the President’s Council of Economic Advisers, senior director for health care policy at the White House, and Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.
He has twice received the Arrow Award for Outstanding Research in Health Economics. He earned his MD degree from the Harvard-MIT Division of Health Sciences and Technology and his PhD in Economics from MIT. He completed his residency training in internal medicine at Brigham and Women’s Hospital, and he is board-certified in Internal Medicine.
You can view his CV here: https://go.fuqua.duke.edu/data/vbcvpp/mbm57/mbm57-vita.pdf?_ga=2.159116542.570519003.1582848136-1912653498.1581431277
Sara Markowitz is Professor of Economics and Director of Graduate Studies in the Economics Department at Emory University. She holds a joint appointment in the Department of Health Policy and Management in the Rollins School of Public Health and is a Research Associate at the National Bureau of Economics Research. Dr. Markowitz’s research interests are on the economics of healthy and unhealthy behaviors, with an emphasis on the role of public policies in determining health outcomes. She served as an editor of the Southern Economic Journal and is currently on the editorial boards of the Journal of Health Economics and Review of Economics of the Household. Her research has been supported by the National Institutes of Health, the Agency for Healthcare Research and Quality, and the Robert Wood Johnson Foundation.
You can view her CV here: https://saramarkowitz.netlify.com/files/web%20cv%20markowitz%20_2_20.pdf
Professor Craig Garthwaite is the Herman R. Smith Research Professor in Hospital and Health Services, an Associate Professor of Strategy, and the Director of the Program on Healthcare at Kellogg (HCAK). He is an applied economist whose research examines the business of healthcare with a focus on the interaction between private firms and public policies. His recent work in the payer and provider sectors has focused on the private sector effects of the Affordable Care Act, the impact and operation of Medicaid Managed Care plans, the responses of non-profit hospitals to financial shocks, and the economic effects of expanded social insurance programs such as Medicaid and Medicare for All.
Professor Garthwaite also studies questions of pricing and innovation in the biopharmaceutical sector. In this area he has examined the effect of changes in market size of investments in new product development, the evolving world of precision medicine, expanded patent protection on pricing in the Indian pharmaceutical market, the innovation response of United States pharmaceutical firms to increases in demand, and the relationship between health insurance expansions and high drug prices.
His research has appeared in journals such as the Quarterly Journal of Economics, the American Economic Review, the Annals of Internal Medicine, and the New England Journal of Medicine. In addition, he is a frequent media commentator appearing in media outlets such as the Wall Street Journal, the Washington Post, and The New York Times. He has also appeared as a guest on various television and radio shows such as Nightly Business Report and NPR Marketplace. In 2015, Professor Garthwaite was named one of Poet and Quants 40 Best under 40 Business School Professors.
Garthwaite received a B.A. and a Masters in Public Policy from the University of Michigan and his PhD in Economics from the University of Maryland. Prior to receiving his PhD, he served in a variety of public policy positions including the Director of Research for the Employment Policies Institute. He has testified before the United States Senate, United States House of Representatives and state legislatures on matters related to the healthcare markets, prescription drugs, the minimum wage, and health care reforms.